IDEX Corporation has successfully finalized the acquisition of 100% of the share capital of Muon Group, marking a transformative addition to its Health & Science Technology (HST) segment. This strategic transaction represents a significant expansion of the group's micro-precision manufacturing capabilities, specifically targeting high-growth sectors with extreme technical requirements such as semiconductors and advanced medical diagnostics. The strategic rationale for the move centers on the high degree of cultural and technical alignment between the two organizations, both of which specialize in highly engineered solutions for mission-critical applications where failure is not an option. By incorporating this technical specialist, the organization reinforces its global leadership in fluid handling while gaining access to proprietary expertise in multi-material micro-machining. The partnership is designed to capitalize on the accelerating demand for miniaturization in industrial processes, combining the group’s industrialized scale and operating rigor with the target’s innovation-led micro-fluidic systems. This integration facilitates the development of next-generation high-precision components, providing the strategic depth required to navigate complex global supply chains in the high-tech and healthcare industries. The move solidifies the group’s standing as a primary enabler of technological advancement in niche precision engineering.

MUON GROUP, which reported an EBITDA margin of LOGIN in 2022, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 10.2x average currently observed in the Industry & Manufacturing sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.